C-MER Eye Care Holdings Limited (HK:3309)
:3309
Want to see HK:3309 full AI Analyst Report?
3309 Stock Chart & Stats
HK$1.70
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.70
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.23 - HK$2.16
Previous CloseN/A
Volume360.00K
Average Volume (3M)495.46K
Market Cap
HK$1.57B
Enterprise ValueHK$1.58B
Total Cash (Recent Filing)HK$465.96M
Total Debt (Recent Filing)HK$426.78M
Price to Earnings (P/E)20.7
Beta1.08
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.2%
Share Statistics
EPS (TTM)0.04
Shares Outstanding1,232,342,900
10 Day Avg. Volume419,185
30 Day Avg. Volume495,465
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.17
Price to Sales (P/S)1.07
P/FCF Ratio9.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Positive Operating Cash FlowSustained positive operating and free cash flow over multiple years provides durable internal funding for clinic maintenance, equipment refreshes and selective network expansion, reducing reliance on external capital and supporting resilience across medical service cycles.
Moderate And Manageable LeverageA moderate debt profile with improving equity gives the company financial flexibility to invest in growth or weather downturns. Manageable leverage supports credit access, tolerates cyclical patient volumes, and reduces refinancing stress over the medium term.
Revenue Expansion With Margin RecoveryMaterial revenue growth combined with improved operating margins and a return to net profitability in 2025 indicates structural demand and better cost absorption. This supports sustainable cash conversion and the potential to scale higher-margin procedures.
Bears Say
Earnings Volatility And Intermittent LossesRepeated swings between profit and loss reduce predictability of free cash flow and complicate long-term planning. For a healthcare services operator, this can hinder capacity investments, staff retention and consistent reinvestment in clinical capabilities.
Inconsistent Returns To ShareholdersIrregular shareholder returns signal that profitability has not been reliably converted into distributable cash. This can constrain dividend policy, make equity financing less attractive, and reduce investor confidence in long-term capital allocation.
Year-to-year Free Cash Flow Volatility And Limited Ratio ConfirmationAbsolute free cash flow is healthy but volatile and missing ratio confirmations limit visibility into conversion trends. This complicates stress testing, lender assessments and long-term forecasting for capacity expansion or acquisitions.
C-MER Eye Care Holdings Limited News
3309 FAQ
What was C-MER Eye Care Holdings Limited’s price range in the past 12 months?
C-MER Eye Care Holdings Limited lowest stock price was HK$1.23 and its highest was HK$2.16 in the past 12 months.
What is C-MER Eye Care Holdings Limited’s market cap?
C-MER Eye Care Holdings Limited’s market cap is HK$1.57B.
When is C-MER Eye Care Holdings Limited’s upcoming earnings report date?
C-MER Eye Care Holdings Limited’s upcoming earnings report date is Sep 01, 2026 which is in 126 days.
How were C-MER Eye Care Holdings Limited’s earnings last quarter?
C-MER Eye Care Holdings Limited released its earnings results on Mar 27, 2026. The company reported HK$0.042 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.042.
Is C-MER Eye Care Holdings Limited overvalued?
According to Wall Street analysts C-MER Eye Care Holdings Limited’s price is currently Overvalued.
Does C-MER Eye Care Holdings Limited pay dividends?
C-MER Eye Care Holdings Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 1.2%. See more information on C-MER Eye Care Holdings Limited dividends here
What is C-MER Eye Care Holdings Limited’s EPS estimate?
C-MER Eye Care Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C-MER Eye Care Holdings Limited have?
C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding.
What happened to C-MER Eye Care Holdings Limited’s price movement after its last earnings report?
C-MER Eye Care Holdings Limited reported an EPS of HK$0.042 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.6%.
Which hedge fund is a major shareholder of C-MER Eye Care Holdings Limited?
Currently, no hedge funds are holding shares in HK:3309
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
C-MER Eye Care Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.66%
12-Months-Change
Fundamentals
Return on Equity
5.64%
Trailing 12-Months
Asset Growth
0.46%
Trailing 12-Months
Company Description
C-MER Eye Care Holdings Limited
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. It operates through the Provision of Ophthalmic Services and the Sale of Vision Aid Products segments. The company was founded by Shun Chiu Lam on February 1, 2016 and is headquartered in Hong Kong.
Technical Analysis
Options Prices
Currently, No data available
---